BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2010
View Archived Issues
Truvada well tolerated in HIV-1-infected pregnant women and neonates
Read More
QNL-111 shown to inhibit HIV-1 DNA integration
Read More
Vicriviroc does not meet primary endpoint in two phase III trials in HIV
Read More
C5A inhibits HIV-1 and HSV in preclinical studies
Read More
Pfizer describes novel kappa opioid receptor antagonists
Read More
Novel serotonin 5-HT6 receptor antagonists patented by Janssen
Read More
Bristol-Myers Squibb discloses new transcription factor AP-1 inhibitors
Read More
Merck KGaA identifies novel PDK1 inhibitors
Read More
Ambit Biosciences claims novel Janus kinase inhibitors
Read More
Novel dual PI3K alpha and mTOR inhibitors described by S*BIO
Read More
Resverlogix activates first site in phase II ASSURE 1 trial of RVX-208 in ACS
Read More
Fourth quarter highlights at Merck & Co.
Read More
Adeona completes 50% of enrollment in Trimesta trial in multiple sclerosis
Read More
GlycoVaxyn begins clinical trial of bioconjugate GVXN-SD-133 Shigella vaccine
Read More
Akebia initiates phase Ib trial of AKB-6548 for anemia
Read More
Fluticasone nasal spray ineffective in irritant rhinitis in pilot trial
Read More
TMTI awards SIGA contract for development broad-spectrum antiviral ST-669
Read More
Global Health Ventures to begin European trials of X-Excite for erectile dysfunction
Read More
Corcept Therapeutics begins phase I CORT-108297 trial
Read More
Rockwell Medical reports phase IIb data on soluble ferric pyrophosphate
Read More
Johnson & Johnson reviews fourth quarter of 2009
Read More
Actelion reports on BUILD-3 trial of bosentan in idiopathic pulmonary fibrosis
Read More
FDA issues refuse to file letter to Adventrx on vinorelbine NDA
Read More
Virginia G. Piper Cancer Center and TGen begin phase I trial of Pharmacyclics' PCI-32765 in cancer
Read More
FDA grants marketing approval for Shire's VPRIV for type 1 GD
Read More
